Cancer is still the leading cause of death. While traditional treatments such as surgery, chemotherapy and radiotherapy play dominating roles, recent breakthroughs in cancer immunotherapy indicate that the influence of immune system on cancer development is virtually beyond our expectation. Manipulating the immune system to fight against cancer has been thriving in recent years. Further understanding of tumor anatomy provides opportunities to put a brake on immunosuppression by overcoming tumor intrinsic resistance or modulating tumor microenvironment. Nanotechnology which provides versatile engineered approaches to enhance therapeutic effects may potentially contribute to the development of future cancer treatment modality. In this review, we will focus on the application of nanotechnology both in boosting anti-tumor immunity and collapsing tumor defense.
基金:
National Natural Science Foundation of China [81373360, 81673374]; Fundamental Research Funds for the Central Universities [2015ZDTD048]
第一作者单位:[1]Tongji Sch Pharm, Wuhan, Hubei, Peoples R China
通讯作者:
通讯机构:[1]Tongji Sch Pharm, Wuhan, Hubei, Peoples R China[3]Natl Engn Res Ctr Nanomed, Wuhan, Hubei, Peoples R China[4]Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714):
Hu Xiaomeng,Wu Tingting,Bao Yuling,et al.Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense[J].JOURNAL OF CONTROLLED RELEASE.2017,256:26-45.doi:10.1016/j.jconrel.2017.04.026.
APA:
Hu, Xiaomeng,Wu, Tingting,Bao, Yuling&Zhang, Zhiping.(2017).Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense.JOURNAL OF CONTROLLED RELEASE,256,
MLA:
Hu, Xiaomeng,et al."Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense".JOURNAL OF CONTROLLED RELEASE 256.(2017):26-45